It can design new antibiotics to stop the spread of Acinetobacter baumannii, which the World Health Organization has identified as one of the world’s most dangerous antibiotic-resistant bacteria.
Led by CEO John Valliant, the company that develops next-generation precision cancer medicines will become a wholly owned subsidiary of AstraZeneca and continue its operations at its state-of-the-art facility at McMaster Innovation Park.
Remote cognitive behavioural therapy (CBT) with a therapist is an effective tool for providing more accessible care to Canadians, research shows.